Target/Pathway Enrichment Report

Mapping Details for your submissionhelp

# Active Inactive
Your Submission 661 301010
Mapped to Target 661 301010
Mapped to Reactome 661 301010
Mapped to GO 661 301010

Table 1. Target/MultiTarget Enrichment help

View Full Report

# TARGET/MULTI-TARGET Odds Ratio p-value kA size
Active
kB size
InActive
1 gi:1669525 inhibitor (assay: 1379)
153.54 3.21e-241 139 661 353 257754
2 gene: PGKC inhibitor (gi:115503961, assay: 686980)
140.3 1.34e-129 77 661 214 257754
3 gene: PGKC inhibitor (gi:115503961, 3 assays integrated)
123.56 6.47e-126 77 661 243 257754
4 gi:290753097 inhibitor (assay: 1721)
77.98 2.11e-251 169 661 845 257754
5 gene: TNFSF10 potentiator (gi:4507593, assay: 1443)
61.21 6.22e-148 108 661 688 257754

Table 2. Pathway Enrichment help

View Full Report

# GO Term Odds Ratio p-value kA size
Active
kB size
InActive
1 (inhibitor) Regulation of IFNA signaling 27.21 2.49e-86 83 528 987 170890
2 (inhibitor) Interferon alpha/beta signaling 27.18 2.69e-86 83 528 988 170890
3 (interactor) Death Receptor Signalling 23.04 3.16e-198 194 528 2725 170890
4 (inhibitor) Caspase activation via extrinsic apoptotic signalig pathway 21.36 1.59e-257 252 528 3818 170890
5 (interactor) Caspase activation via extrinsic apoptotic signalig pathway 19.5 5.03e-186 195 528 3236 170890

Table 3. GO term Enrichment help

View Full Report

# GO Term Odds Ratio p-value kA size
Active
kB size
InActive
1 (inhibitor) extracellular vesicle 268.92 6.38e-116 61 559 78 192226
2 (inhibitor) organ regeneration 218.5 1.04e-111 61 559 96 192226
3 (inhibitor) response to insulin 205.65 1.93e-110 61 559 102 192226
4 (inhibitor) glycolytic process 42.54 1.21e-73 61 559 493 192226
5 (inhibitor) skeletal muscle cell differentiation 36.75 3.55e-71 62 559 580 192226